NO980546D0 - Farmasöytiske midler - Google Patents

Farmasöytiske midler

Info

Publication number
NO980546D0
NO980546D0 NO980546A NO980546A NO980546D0 NO 980546 D0 NO980546 D0 NO 980546D0 NO 980546 A NO980546 A NO 980546A NO 980546 A NO980546 A NO 980546A NO 980546 D0 NO980546 D0 NO 980546D0
Authority
NO
Norway
Prior art keywords
pharmaceutical agents
pharmaceutical
agents
Prior art date
Application number
NO980546A
Other languages
English (en)
Other versions
NO980546L (no
Inventor
Mitchell Irvin Steinberg
Fatima Emitsel Yakubu-Madus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO980546D0 publication Critical patent/NO980546D0/no
Publication of NO980546L publication Critical patent/NO980546L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO980546A 1997-02-11 1998-02-09 Farmas°ytiske midler NO980546L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79866197A 1997-02-11 1997-02-11

Publications (2)

Publication Number Publication Date
NO980546D0 true NO980546D0 (no) 1998-02-09
NO980546L NO980546L (no) 1998-08-12

Family

ID=25173964

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980546A NO980546L (no) 1997-02-11 1998-02-09 Farmas°ytiske midler

Country Status (12)

Country Link
EP (1) EP0857483A1 (no)
JP (1) JPH10218773A (no)
KR (1) KR19980071226A (no)
AU (1) AU5387898A (no)
CA (1) CA2229123A1 (no)
CZ (1) CZ39398A3 (no)
HU (1) HUP9800291A2 (no)
IL (1) IL123232A0 (no)
MX (1) MX9801129A (no)
NO (1) NO980546L (no)
SG (1) SG76535A1 (no)
ZA (1) ZA981029B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2727400A (en) * 1999-01-29 2000-08-18 Eli Lilly And Company Moxonidine salts
ITTV20010002U1 (it) 2001-01-12 2002-07-12 Vetraria Biancadese Sas Soc Tavolo avente almeno una prolunga estraibile mediante semplice rotazione
PL377847A1 (pl) 2003-01-14 2006-02-20 Arena Pharmaceuticals Inc. 1,2,3-Tripodstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie związanych z nim zaburzeń takich jak cukrzyca i hiperglikemia
EP1606282B1 (en) * 2003-02-24 2008-11-12 Arena Pharmaceuticals, Inc. Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
BRPI0415198A (pt) * 2003-10-10 2006-12-05 Solvay Pharm Gmbh composição farmacêutica compreendendo um agonista seletivo do receptor da imidazolina i1 e um bloqueador do receptor da angiotensina ii
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
EP1981498A2 (en) * 2006-01-27 2008-10-22 F. Hoffmann-la Roche AG Use of 2-imidazoles for the treatment of cns disorders
ES2381589T3 (es) 2006-10-19 2012-05-29 F. Hoffmann-La Roche Ag Aminometil-4-imidazoles
WO2008052907A1 (en) 2006-11-02 2008-05-08 F. Hoffmann-La Roche Ag Substituted 2-imidazoles as modulators of the trace amine associated receptors
RU2456281C2 (ru) 2006-11-16 2012-07-20 Ф. Хоффманн-Ля Рош Аг Замещенные 4-имидазолы, способ их получения и их применение
AU2007332641A1 (en) 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag Novel 2 -imidazoles as ligands for trace amine associated receptors (TAAR)
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
RU2473545C2 (ru) 2007-02-02 2013-01-27 Ф.Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1 для заболеваний цнс
RU2460725C2 (ru) 2007-02-15 2012-09-10 Ф. Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1
MX2009013742A (es) 2007-07-02 2010-01-26 Hoffmann La Roche 2-imidazolinas.
AU2008270444A1 (en) 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
RU2010104632A (ru) 2007-07-27 2011-09-20 Ф.Хоффманн-Ля Рош Аг (Ch) 2-азетидинметанамины и 2-пирролидинметанамины в качестве лигандов taar
JP5341084B2 (ja) 2007-08-03 2013-11-13 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒ１リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
BR112013008100A2 (pt) 2010-09-22 2016-08-09 Arena Pharm Inc "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles."
EP2829540A1 (en) 2013-07-26 2015-01-28 Abbott Healthcare Products B.V. Synthesis of substituted aminopyridines
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
SI3310760T1 (sl) 2015-06-22 2023-02-28 Arena Pharmaceuticals, Inc. Kristalinična L-argininska sol (R)-2-(7-(4-ciklopentil-3-(trifluorometil)benziloksi)-1,2,3,4- tetrahidrociklo-penta(b)indol-3-il)ocetne kisline za uporabo pri motnjah, povezanih z receptorjem S1P1
RU2731095C2 (ru) 2016-03-17 2020-08-28 Ф. Хоффманн-Ля Рош Аг Производное 5-этил-4-метил-пиразол-3-карбоксамида, обладающее активностью агониста taar

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel

Also Published As

Publication number Publication date
JPH10218773A (ja) 1998-08-18
KR19980071226A (ko) 1998-10-26
AU5387898A (en) 1998-08-13
IL123232A0 (en) 1999-11-30
HU9800291D0 (en) 1998-04-28
EP0857483A1 (en) 1998-08-12
CA2229123A1 (en) 1998-08-11
NO980546L (no) 1998-08-12
HUP9800291A2 (hu) 2001-02-28
CZ39398A3 (cs) 1998-08-12
MX9801129A (es) 1998-11-29
SG76535A1 (en) 2000-11-21
ZA981029B (en) 1999-08-10

Similar Documents

Publication Publication Date Title
ID23874A (id) Obat
NO980546D0 (no) Farmasöytiske midler
ID24654A (id) Formulasi farmasi omeprazola
DE69831181D1 (de) Positionsbestimmung
DE69817568D1 (de) Elektrochemilumineszenzdetektor
DE69800755T2 (de) Strohbauplatte
DE69820407D1 (de) Blisterpackung
DK1017392T3 (da) Lægemiddel
IS5331A (is) Ný lyfjablanda
NO995147D0 (no) Kontrastmidler
NO994619L (no) Farmasöytiske blandinger
NO20003141D0 (no) Farmasøytiske blandinger
ATA112597A (de) Snowboard - bindung
ID23531A (id) Komposisi farmasi
FI973712A0 (fi) Visningselement
FI974274A0 (fi) Abonnentlinjekrets
ID21180A (id) Senyawa-senyawa farmasi
NO974138D0 (no) Kontrastmidler
BR1100755A (pt) composição farmacêutica
UA25523A (uk) Лікувальhий препарат гірчичhик
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
DE69721214D1 (de) Blisterverpackung
FR2771676B1 (fr) Livre
DK0969815T3 (da) Farmaceutiske præparater
SE9702958D0 (sv) Pharmaceuticals